FDA Urged to Protect Patients from Payer-Mandated Drug Distribution Model

March 31, 2021

The AHA and American Society of Health-System Pharmacists urge the Food and Drug Administration to take appropriate enforcement action to protect patients from a payer-mandated drug distribution model known as “white bagging.”

Under the white bagging model, payers require patients to receive their medications through a narrow network of specialty pharmacies often affiliated with the payer, and providers to hold the medications until the patient arrives for treatment. 

View the entire letter under Key Resources.

Related Resources

Letter/Comment
Member
AHA urges the Centers for Medicare & Medicaid Services to align the Hospital Price Transparency Rule with new transparency requirements included in the No…
Issue Landing Page
Member Non-Fed
Commercial health plan abuses must be addressed to ensure fair coverage for patients and providers. The AHA has worked to hold health plans accountable through…
Letter/Comment
Public
The AHA requests that the Federal Trade Commission use its resources to tackle several issues that are adversely impacting hospitals as well as reconsider its…
Special Bulletin
Member
The Centers for Medicare…
Letter/Comment
Public
AHA comments on CMS’ proposed rule on prior authorization.
Letter/Comment
Public
December 18, 2020 The Honorable Nancy Pelosi Speaker U.S. House of Representatives Washington, DC 20515 The Honorable Mitch McConnell Majority Leader U.S…